2-(3-Aryl-2-propenoyl)-3-methylquinoxaline-1,4-dioxides: a novel cluster of tumor-specific cytotoxins which reverse multidrug resistance.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Bioorganic & Medicinal Chemistry

• Publication date

  2009-06-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.bmc.2009.04.021PMID 19427790PMCID PMC3276588
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• 1-[4-(2-Aminoethoxy)phenylcarbonyl]-3,5-bis-(benzylidene)-4-oxopiperidines: a novel series of highly potent revertants of P-glycoprotein associated multidrug resistance.

  2008cited by this paper
• 2-(3-ARYLACRYLOYL)-3-METHYLQUINOXALINE 1,4-DIOXIDES AS POTENTIAL HYPOXIC SELECTIVE CYTOTOXINS

  2008cited by this paper
• E,E-2-Benzylidene-6-(nitrobenzylidene)cyclohexanones: syntheses, cytotoxicity and an examination of some of their electronic, steric, and hydrophobic properties.

  2008cited by this paper
• Cytotoxic 3,5-bis(benzylidene)piperidin-4-ones and N-acyl analogs displaying selective toxicity for malignant cells.

  2008cited by this paper
• 1-Aryl-2-dimethylaminomethyl-2-propen-1-one hydrochlorides and related adducts: A quest for selective cytotoxicity for malignant cells.

  2008cited by this paper
• 3-(3,4,5-Trimethoxyphenyl)-1-oxo-2-propene: a novel pharmacophore displaying potent multidrug resistance reversal and selective cytotoxicity.

  2007cited by this paper
• Cytotoxic thiol alkylators.

  2007cited by this paper
• Cytotoxic 5-aryl-1-(4-nitrophenyl)-3-oxo-1,4-pentadienes mounted on alicyclic scaffolds.

  2006cited by this paper
• 3-Arylidene-1-(4-nitrophenylmethylene)-3,4-dihydro-1H-naphthalen-2-ones and related compounds displaying selective toxicity and reversal of multidrug resistance in neoplastic cells.

  2005cited by this paper
• Sensitization for anticancer drug-induced apoptosis by betulinic Acid.

  2005cited by this paper
• Pharmaceutical‐mediated inactivation of p53 sensitizes U87MG glioma cells to BCNU and temozolomide

  2005cited by this paper
• Smith and Williams' Introduction to the Principles of Drug Design and Action

  2005cited by this paper
• Coumarin derivatives with tumor-specific cytotoxicity and multidrug resistance reversal activity.

  2005cited by this paper
• Design, synthesis, and biological evaluation of hybrid molecules containing alpha-methylene-gamma-butyrolactones and polypyrrole minor groove binders.

  2004cited by this paper
• Biological activity of barbados cherry (acerola fruits, fruit of Malpighia emarginata DC) extracts and fractions

  2004cited by this paper
• Some practical considerations and applications of the national cancer institute in vitro anticancer drug discovery screen

  1995cited by this paper
• A new route for the synthesis of phenazine di-N-oxides

  1995cited by this paper
• X-ray structural characterization of anhydrous metronidazole benzoate and metronidazole benzoate monohydrate.

  1993cited by this paper
• Degradation and inactivation of antitumor drugs.

  1993cited by this paper
• The National Cancer Institute: cancer drug discovery and development program.

  1992cited by this paper
• The relevance of tumour pH to the treatment of malignant disease.

  1984cited by this paper
• pKa prediction for organic acids and bases

  1981cited by this paper
• Substituent constants for correlation analysis in chemistry and biology

  1979cited by this paper
• Interdependence between physical parameters and selection of substituent groups for correlation studies.

  1971cited by this paper

• Flavonoid‐Quinoxaline Hybrid Compounds as Cathepsin Inhibitors Against Fascioliasis

  2024cites this paper
• Quinoxaline 1,4-Dioxides: Advances in Chemistry and Chemotherapeutic Drug Development

  2023cites this paper
• Isocyanide-Based Multicomponent Reactions in Water: Advanced Green Tools for the Synthesis of Heterocyclic Compounds

  2022cites this paper
• Biological activity of esters of quinoxaline-7-carboxylate 1,4-di-N-oxide against E. histolytica and their analysis as potential thioredoxin reductase inhibitors

  2020cites this paper
• Six-membered N,N-polyheterocycles

  2020cites this paper
• Revision of the Regioselectivity of the Beirut Reaction of Monosubstituted Benzofuroxans with Benzoylacetonitrile. 6-Substituted quinoxaline-2-carbonitrile 1,4- dioxides: Structural Characterization and Estimation of Anticancer Activity and Hypoxia Selectivity.

  2020cites this paper
• Recent advances in α,β-unsaturated carbonyl compounds as mitochondrial toxins.

  2019cites this paper
• Chemistry and pharmacological diversity of quinoxaline motifs as anticancer agents

  2019cites this paper
• The Design and Development of Potent Small Molecules as Anticancer Agents Targeting EGFR TK and Tubulin Polymerization

  2018cites this paper
• Synthesis, In-Vitro Activity and Metabolic Properties of Quinocetone and Structurally Similar Compounds

  2017cites this paper
• Quinoxaline 1,4-di-N-Oxides: Biological Activities and Mechanisms of Actions

  2016cites this paper
• Quinoxaline Nucleus: A Promising Scaffold in Anti-cancer Drug Discovery.

  2016cites this paper
• Synthesis of Quinoxalines

  2016cites this paper
• SAR-guided development and characterization of a potent antitumor compound toward B-cell neoplasms with no detectable cytotoxicity toward healthy cells.

  2015cites this paper
• Part I: Nitroalkenes in the synthesis of heterocyclic compounds

  2014cites this paper
• Present status of quinoxaline motifs: excellent pathfinders in therapeutic medicine.

  2014cites this paper
• Synthesis, Biological Evaluation and Structure-Activity Relationships of New Quinoxaline Derivatives as Anti-Plasmodium falciparum Agents

  2014cites this paper
• Arylglyoxals in synthesis of heterocyclic compounds.

  2013cites this paper
• Antibacterial derivative of quinoxaline-1,4-dioxide and application in animal production thereof

  2013cites this paper
• The properties and the use of substituted benzofuroxans in pharmaceutical and medicinal chemistry: a comprehensive review.

  2013cites this paper
• Synthesis and biological evaluation of 1,7,8,8a-tetrahydro-3H-oxazolo[3,4-a]pyrazin-6(5H)-ones as antitumoral agents.

  2013cites this paper
• Anthranilic acid-based diamides derivatives incorporating aryl-isoxazoline pharmacophore as potential anticancer agents: design, synthesis and biological evaluation.

  2012cites this paper
• ENHANCEMENT OF THE CYTOTOXIC ACTIVITY OF SOME α,β-UNSATURATED KETONES THROUGH AUXILIARY BINDING

  2012cites this paper
• Near Room Temperature Cross‐Coupling Reactions of Arene Boronic Acids with a Quinoxaline 1,4‐Dioxide Benzylsulfanyl Derivative

  2012cites this paper
• Anticancer drug design using scaffolds of β-lactams, sulfonamides, quinoline, quinoxaline and natural products. Drugs advances in clinical trials.

  2012cites this paper
• Transition metal complexes of thiosemicarbazones with quinoxaline hub: an emphasis on antidiabetic property

  2011cites this paper
• E-2-[3-(3,4-dichlorophenyl)-1-oxo-2-propenyl]-3-methylquinoxaline-1,4-dioxide: a lead antitubercular agent which alters mitochondrial respiration in rat liver.

  2010cites this paper
• First synthesis of 2-phosphonylated quinoxaline 1,4-dioxides: an extension to the Beirut reaction

  2010cites this paper
• Aromatic 2-(thio)ureidocarboxylic acids as a new family of modulators of multidrug resistance-associated protein 1: synthesis, biological evaluation, and structure-activity relationships.

  2009cites this paper
• Development of Ortho-Substituted Aromatic (Thio)ureas and Derived Heterocycles as Modulators of P-Glycoprotein and Multidrug Resistance-Associated Protein 1

  2009cites this paper